NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients

The risk of developing metastatic disease in breast cancer patients is traditionally predictable based on the number of positive axillary lymph nodes, complemented with additional clinicopathological factors. However, since lymph node-negative patients have a 20–30% probability of developing metasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Jandrey, Elisa H. F., Moura, Ricardo P., Andrade, Luciana N. S., Machado, Camila L., Campesato, Luiz Felipe, Leite, Katia Ramos M., Inoue, Lilian T., Asprino, Paula F., da Silva, Ana Paula M., de Barros, Alfredo Carlos S. D., Carvalho, Andre, de Lima, Vladmir C., Carraro, Dirce M., Brentani, Helena P., da Cunha, Isabela W., Soares, Fernando A., Parmigiani, Raphael B., Chammas, Roger, Camargo, Anamaria A., Costa, Érico T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450950/
https://www.ncbi.nlm.nih.gov/pubmed/30963110
http://dx.doi.org/10.1038/s41523-019-0106-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450950/
https://www.ncbi.nlm.nih.gov/pubmed/30963110
http://dx.doi.org/10.1038/s41523-019-0106-x

Ejemplares similares